Vicore Pharma Ownership

Stocks . Sweden . 
Stock . Vicore Pharma Holding
VICO Stock  SEK 7.65  0.14  1.80%   
Vicore Pharma Holding shows a total of 81.85 Million outstanding shares. Over half of Vicore Pharma's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Vicore Pharma Holding. Please watch out for any change in the institutional holdings of Vicore Pharma as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vicore Pharma Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Vicore Stock Ownership Analysis

About 16.0% of the company outstanding shares are owned by insiders. The company has Price/Earnings (P/E) ratio of 163.82. Vicore Pharma Holding recorded a loss per share of 4.76. The entity had not issued any dividends in recent years. The firm had 396:347 split on the 14th of September 2018. Vicore Pharma Holding AB , through its subsidiaries, operates as a biotech company. Vicore Pharma Holding AB was founded in 2000 and is based in Mlndal, Sweden. Vicore Pharma is traded on Stockholm Stock Exchange in Sweden. For more information please call the company at 46 3 17 88 05 60 or visit https://www.vicorepharma.com.

Vicore Pharma Outstanding Bonds

Vicore Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Vicore Pharma Holding uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Vicore bonds can be classified according to their maturity, which is the date when Vicore Pharma Holding has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp Bond
US235822AB96		View
MPLX LP 4125 Corp Bond
US55336VAK61		View
MPLX LP 4875 Corp Bond
US55336VAJ98		View
MPLX LP 52 Corp Bond
US55336VAL45		View
BNP Paribas FRN Corp Bond
USF1R15XK367		View
Morgan Stanley 3591 Corp Bond
US61744YAK47		View
Morgan Stanley 3971 Corp Bond
US61744YAL20		View
MGM Resorts International Corp Bond
US552953CD18		View

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vicore Stock Analysis

When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY